tiprankstipranks
Agilon Health (AGL)
NYSE:AGL
US Market

Agilon Health (AGL) Technical Analysis

Compare
272 Followers

Technical Sentiment

Overall Consensus
Buy
8Bullish
0Neutral
5Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Agilon Health’s (AGL) Moving Averages Convergence Divergence (MACD) indicator is 0.25, suggesting Agilon Health is a Buy.
Agilon Health’s (AGL) 20-Day exponential moving average is 4.12, while Agilon Health’s (AGL) share price is $4, making it a Buy.
Agilon Health’s (AGL) 50-Day exponential moving average is 3.75, while Agilon Health’s (AGL) share price is $4, making it a Buy.

Agilon Health (AGL) Pivot Points

Apr 05, 2025, 05:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.04
4.14
4.23
4.33
4.42
4.52
4.61
Fibonacci
4.14
4.21
4.25
4.33
4.40
4.44
4.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agilon Health (AGL) Moving Averages

Apr 05, 2025, 05:10 AM
Period
Simple
Exponential
MA5
4.13Buy
4.15Sell
MA10
4.32Sell
4.21Sell
MA20
4.21Sell
4.12Buy
MA50
3.74Buy
3.75Buy
MA100
2.96Buy
3.52Buy
MA200
3.81Buy
4.09Buy
Agilon Health’s (AGL) 10-Day exponential moving average is 4.21, while Agilon Health’s (AGL) share price is $4, making it a Sell.
Agilon Health’s (AGL) 100-Day exponential moving average is 3.52, while Agilon Health’s (AGL) share price is $4, making it a Buy.
Agilon Health’s (AGL) stock price is $4 and Agilon Health’s (AGL) 50-day simple moving average is 3.74, creating a Buy signal.
Agilon Health’s (AGL) stock price is $4 and Agilon Health’s (AGL) 100-day simple moving average is 2.96, creating a Buy signal.
Agilon Health’s (AGL) stock price is $4 and Agilon Health’s (AGL) 200-day simple moving average is 3.81, creating a Buy signal.

Agilon Health (AGL) Technical Indicators

Apr 05, 2025, 05:10 AM
Name
Value
Implied Action
RSI (14)
51.70
Neutral
STOCH (9,6)
39.64
Neutral
STOCHRSI (14)
54.66
Neutral
MACD (12,26)
0.25
Buy
ADX (14)
16.80
Buy
Williams %R
-76.07
Buy
CCI (14)
11.13
Neutral
ATR (14)
0.29
-
Ultimate Oscillator
44.36
Neutral
ROC
-1.19
Sell
Agilon Health’s (AGL) Relative Strength Index (RSI) is 51.70, creating a Neutral signal.
Agilon Health’s (AGL) Trend Strength Indicator (ADX) is 16.80, creating a Buy signal.
Agilon Health’s (AGL) Commodity Channel Index (CCI) is 11.13, creating a Neutral signal.
Agilon Health’s (AGL) Price Rate of Change (ROC) is -1.19, creating a Sell signal.

FAQ

Is AGL a Buy, Hold, or Sell?
Based on AGL’s technical indicators, AGL is a Buy.
    What is AGL’s RSI (14)?
    AGL’s RSI (14) is 51.70, which suggests AGL is a Neutral.
      What is AGL’s MACD?
      AGL’s MACD is 0.25, which suggests AGL is a Buy.
        What is AGL’s 5-day moving average?
        AGL’s 5-day moving average is 4.13, which suggests AGL is a Buy.
          What is AGL’s 20-day moving average?
          AGL 20-day moving average is 4.21, which suggests AGL is a Sell.
            What is AGL’s 50-day moving average?
            AGL’s 50-day moving average is 3.74, which suggests AGL is a Buy.
              What is AGL’s 200-day moving average?
              AGL’s 200-day moving average is 3.81, which suggests AGL is a Buy.
                What is AGL’s Williams % R (14)?
                AGL’s Williams % R (14) is -76.07, which suggests AGL is a Buy.
                  What is AGL’s CCI (14)?
                  AGL’s CCI (14) is 11.13, which suggests AGL is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis